Their findings indicated that cGAMP-NPs can modulate the TME in PD-L1-insensitive TNBC tumours and can produce antitumour memory to prevent secondary tumour development on a single dose, potentially enhancing their responsiveness to immunotherapy [56]. This evidence concerns the gene CD274 and neoplasm.